Clinical Trial Update: The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels [Phase 4]

View source ↗

Summary

This Phase 4 study examines how 5-aminosalicylates affect thiopurine metabolite levels in patients with Crohn's disease and ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)
• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Crohn's Disease, Ulcerative Colitis | Phase 4 | Status: COMPLETED